Providing Guaranteed Compliance with the coast guard's drug
testing regulation, with over 9000 members

November 10, 2017

Today the Department of Transportation  amended its drug-testing program regulation to add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel; add methylenedioxyamphetamine (MDA) as an initial test analyte; and remove methylenedioxyethylamphetamine (MDA) as a confirmatory test analyte. 
The revision of the drug-testing panel harmonizes DOT regulations with the revised HHS Mandatory Guidelines established by the U.S. Department of Health and Human Services for Federal drug-testing programs for urine testing. This final rule clarifies certain existing drug-testing program provisions and definitions, makes technical amendments, and removes the requirement for employers and Consortium/Third Party Administrators to submit blind specimens.
This rule is effective on January 1, 2018.
To learn more about this final rule, visit ODAPC's web page at 


Joomla SEF URLs by Artio